作为针对糖尿病 - 骨质疏松症联系的新目标,PRKD2
Rongjin Chen1,2,3,4, Chenhui Yang1,2,3,4, Hefang Xiao1,2,3
1Department of Orthopedics, The Second Hospital of Lanzhou University, Lanzhou, 730030, China.
Scientific reports
|February 8, 2025
概括
这项研究确定了PRKD2作为糖尿病和骨质疏松症共患病 (DMOP) 的关键基因. 低调PRKD2影响骨和葡萄糖代谢,这表明它对DMOP的治疗潜力.
科学领域:
- 基因组学就是基因组学.
- 代谢疾病 代谢疾病
- 骨生物学 骨生物学 骨生物学
背景情况:
- 糖尿病 (DM) 和骨质疏松症 (OP) 共同发病 (DMOP) 带来了复杂的健康挑战.
- 了解DMOP的共同遗传基础对于开发有效治疗方法至关重要.
研究的目的:
- 识别和验证参与DMOP病变发生的关键基因.
- 阐明特定基因在从健康状态过渡到DM和DMOP状态中的作用.
主要方法:
- 利用Mfuzz时间序列基因聚类和患者血清的转录组测序.
- 进行了外部数据集验证,功能丰富,基因组丰富和免疫细胞透分析.
- 进行细胞和动物模型研究以验证基因功能.
主要成果:
- 在从健康到DM和DMOP的进展过程中确定了动态基因表达模式.
- 发现PRKD2在DMOP中受到显著的下调.
- PRKD2在Wnt和IL-18信号通路中发挥作用,影响亡和骨代谢.
结论:
- PRKD2是DMOP的发病过程中的一个关键分子.
- 在关键的代谢和骨途径中,PRKD2的参与突显了其治疗潜力.
- 这项研究为DMOP机制提供了新的见解,并将PRKD2确定为有前途的治疗标.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Pathophysiology of Diabetes
848
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
848
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K


